Advocates Urge FDA to Revoke Approval of Painkiller Zohydro By Join Together Staff | February 26, 2014 | More than 40 addiction treatment, health care and consumer groups are urging the Food and Drug Administration (FDA) to reverse its decision to approve the prescription painkiller Zohydro ER (extended release), CNN reports. The drug is a pure form of the painkiller hydrocodone. The FDA approved Zohydro ER in October for patients with pain that requires daily, around-the-clock, long-term treatment that cannot be treated with other drugs. Drugs such as Vicodin contain a combination of hydrocodone and other painkillers such as acetaminophen. Zohydro ER is set to become available in March, the article notes. In December 2012, a panel of experts assembled by the FDA voted against recommending approval of Zohydro ER. The panel cited concerns over the potential for addiction. Zohydro is designed to be released over time, and can be crushed and snorted by people seeking a strong, quick...
Drug Testing, Occupational Healthcare Solutions, On-site Medical Services, First Aid and Nursing Stations. MMC accommodates large scale construction projects to small random drug testing pools - Mobile Medical Corporation- Setting New Standards!